European corporate and pharmaceutical industry expert Dr. Stephen Parker appointed Non-Executive Director • Experienced European corporate, pharmaceutical industry and investment director, Dr. Stephen Parker has been appointed to the MXC Board as Non-Executive Director• His appointment brings MXC 30+ years of experience, deep sector understanding and an extensive network of connections within the pharmaceutical and investment industries • Dr Parker currently holds multiple prestigious Board positions at leading UK listed Biopharma companies, including Sareum Holdings plc and Silence Therapeutics plc.• Dr Parker’s appointment demonstrates MXC’s commitment to developing and expanding its European operations and delivering on its seed-to-pharma growth strategy
European corporate and pharmaceutical industry expert Dr....
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.58M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 31.0¢ | 30.0¢ | $2.567K | 8.41K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 47481 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 8026 | 2 |
View Market Depth
| Last trade - 15.53pm 21/06/2024 (20 minute delay) ? |
| RGT (ASX) Chart |